The first Navidea Biopharmaceuticals trade was made in Q2 2019.
Since then Ken Griffin bought shares eight more times and sold shares on seven occasions. The investor completely sold their stake between Q1 2023 and Q2 2023.
Avg closing price
Price range
Sold -65.8 Thousand shares
Q2 2023
Avg closing price
$0.16
Price range
$0.08
-
$0.29
Sold 29.9% shares (-28 Thousand shares)
Q1 2023
Avg closing price
$0.29
Price range
$0.24
-
$0.34
New holding (+93.8 Thousand shares)
Q4 2022
Avg closing price
$0.25
Price range
$0.18
-
$0.30
Sold -24.2 Thousand shares
Q3 2022
Avg closing price
$0.47
Price range
$0.24
-
$0.71
Increased shares by 37.9% (+6.66 Thousand shares)
Q2 2022
Avg closing price
$0.85
Price range
$0.63
-
$1.10
Sold 70.0% shares (-41 Thousand shares)
Q1 2022
Avg closing price
$0.92
Price range
$0.72
-
$1.20
Increased shares by 39.0% (+16.4 Thousand shares)
Q4 2021
Avg closing price
$1.41
Price range
$1.00
-
$1.82
Sold 34.8% shares (-22.5 Thousand shares)
Q3 2021
Avg closing price
$1.68
Price range
$1.53
-
$1.85
Increased shares by 18.6% (+10.1 Thousand shares)
Q2 2021
Avg closing price
$1.77
Price range
$1.55
-
$2.15
Increased shares by 105.8% (+28 Thousand shares)
Q1 2021
Avg closing price
$2.34
Price range
$1.99
-
$2.90
Sold 13.4% shares (-4.11 Thousand shares)
Q3 2020
Avg closing price
$3.59
Price range
$2.69
-
$4.95
Increased shares by 8.8% (+2.47 Thousand shares)
Q2 2020
Avg closing price
$1.91
Price range
$0.70
-
$4.16
New holding (+28.1 Thousand shares)
Q1 2020
Avg closing price
$1.10
Price range
$0.76
-
$1.54
Sold -28.9 Thousand shares
Q4 2019
Avg closing price
$0.86
Price range
$0.65
-
$1.26
Increased shares by 72.4% (+12.1 Thousand shares)
Q3 2019